Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecobalamin in Preventing Taxane-related Peripheral Neuropathy
NCT07423390Phase 3Recruiting
- Sponsor
- Qinghai Red Cross Hospital
- Start
- Feb 2026
- Primary completion
- Mar 2029
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of mecobalamin in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Qinghai Red Cross Hospital. Started Feb 2026; status: recruiting.
02
Drugs
mecobalamin
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT07423390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07423390.